Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
Chandrashekhar Athare, Associate Director at Innomagine Consulting Private Limited, shared a post on LinkedIn:
“As EHA 2026 comes to a close, I would like to express my gratitude to the organizers, speakers, exhibitors, and fellow attendees for an excellent congress in Stockholm.
Over the past few days, I had the opportunity to learn about the latest advancements in hematology, attend inspiring scientific sessions, and connect with professionals from across the global healthcare and life sciences community.
The insights gained, conversations shared, and connections made will undoubtedly contribute to future collaborations and continued learning.
A special thanks to everyone who took the time to connect and exchange ideas.
I look forward to staying in touch and continuing these discussions beyond the congress.
Until next time—looking forward to EHA 2027!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering